300015 爱尔眼科
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)6.03215.18117.97318.90918.042
总资产报酬率 ROA (%)3.7229.26711.21011.83410.425
投入资产回报率 ROIC (%)4.45011.22813.46014.45513.016

边际利润分析
销售毛利率 (%)46.11847.11348.11750.79350.463
营业利润率 (%)23.61120.59322.99524.29421.940
息税前利润/营业总收入 (%)23.09120.58422.91722.70620.743
净利润/营业总收入 (%)12.91815.53817.80617.95016.692

收益指标分析
经营活动净收益/利润总额(%)108.578104.88994.769115.445118.663
价值变动净收益/利润总额(%)0.1123.91911.920-0.723-9.385
营业外收支净额/利润总额(%)-8.647-4.022-5.020-8.722-5.980

偿债能力分析
流动比率 (X)1.4791.2381.4501.6941.799
速动比率 (X)1.3381.1181.3021.5451.663
资产负债率 (%)32.55836.20334.41033.66333.724
带息债务/全部投入资本 (%)11.3749.3559.0037.5856.723
股东权益/带息债务 (%)647.911789.464822.723999.5261,147.917
股东权益/负债合计 (%)195.103165.494181.019185.555185.995
利息保障倍数 (X)16.99526.14322.43962.811502.145

营运能力分析
应收账款周转天数 (天)28.40930.93833.38930.77634.624
存货周转天数 (天)27.38729.94031.17029.28829.374